Essence Pharmaceuticals: Net profit in the first half of 2025 was 131 million yuan, a year-on-year decrease of 3.54%.

Jinghua Pharmaceutical announced that the operating income in the first half of 2025 was 731 million yuan, an increase of 1.54% year-on-year. The net profit attributable to the shareholders of the listed company was 131 million yuan, a decrease of 3.54% year-on-year. The company plans not to distribute cash dividends, bonus shares, or increase capital reserves by issuing bonus shares.